DAR No 4: Olodaterol. Striverdi® , Respimat® for COPD

Content tools

Share it

Nothing to puff up with pride

Olodaterol is a new long-acting beta2-agonists for control of asthma.
It has only been actively compared with formoterol in terms of improvement of lung function in a small 6-week study, without any significant differences found.
Its safety profile seems to be similar to that of other LABA .
Data supporting its effectiveness when used alone are very limited.

Enviar comentario

You can send us a comment or suggestion and we will respond to most frequently asked questions

Competing interests (complete this field only if you have competing interests)

First name, middle initial and last name *

Email *

Current position or occupation *

Place of work *

Suggestions/Comments *